foxo4-dri for senescent cells alleviates age-related testosterone secretion insufficiency by targeting Leydig in aged mice FOXO4-DRI (Proxofim) (10mg)

After first reconstitution (puncturing the rubber stopper with a sterile needle to introduce bacteriostatic water), the vial's internal environment is exposed, though the rubber stopper reseals when the needle is removed

Who Should Exercise Particular Caution: Pregnant or Nursing Women: No safety data exists for BPC-157 use during pregnancy or lactation

For in-depth microdosing protocols, our microdosing tirzepatide chart provides complete guidance on protocol design, expected outcomes, and titration strategies for sub-2.5mg doses

Hygroscopic, Refrigerator, under inert atmosphere solubility DMSO (Slightly), Methanol (Slightly) form Solid pka 9.830.15(Predicted) color White to Off-White Sequence Hexanoyl-Tyr-Ile-Ahx-NH2 InChIKey ADWKPLXLPNPJTR-JTJYXVOQSA-N SMILES C(N)(=O)[C@H]([C@@H](C)CC)N(C(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)CCCCC)CCCCCC(N)=O Description Dihexa (developmental code name PNB-0408), also known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, is an oligopeptide drug derived from angiotensin IV that binds with high affinity to hepatocyte growth factor (HGF) and potentiates its activity at its receptor, c-Met